Axsome Therapeutics, Inc. Earnings

Axsome Therapeutics, Inc.’s revenue jumped 66.04% since last year same period to $118.77Mn in the Q4 2024. On a quarterly growth basis, Axsome Therapeutics, Inc. has generated 13.37% jump in its revenue since last 3-months.

Axsome Therapeutics, Inc.’s net profit jumped 24.06% since last year same period to $-74.91Mn in the Q4 2024. On a quarterly growth basis, Axsome Therapeutics, Inc. has generated -15.96% fall in its net profits since last 3-months.

Axsome Therapeutics, Inc.’s net profit margin jumped 54.27% since last year same period to -63.08% in the Q4 2024. On a quarterly growth basis, Axsome Therapeutics, Inc. has generated -2.29% fall in its net profit margins since last 3-months.

Axsome Therapeutics, Inc.’s earning per share (EPS) estimates for the current quarter stand at -1.21 - a -20.69% fall from last quarter’s estimates.

Axsome Therapeutics, Inc.’s earning per share (EPS) estimates for the current year stand at -1.21.

Axsome Therapeutics, Inc.’s earning per share (EPS) jumped 25.96% since last year same period to -1.54 in the Q4 2024. This indicates that the Axsome Therapeutics, Inc. has generated 25.96% annual rate of jump in its earning per share (EPS) in the last 4 quarters.